تحميل...

Small molecule PZL318: forming fluorescent nanoparticles capable of tracing their interactions with cancer cells and activated platelets, slowing tumor growth and inhibiting thrombosis

Low selectivity of chemotherapy correlates with poor outcomes of cancer patients. To improve this issue, a novel agent, N-(1-[3-methoxycarbonyl-4-hydroxyphenyl]-β-carboline-3-carbonyl)-Trp-Lys-OBzl (PZL318), was reported here. The transmission electron microscopy, scanning electron microscopy, and a...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Int J Nanomedicine
المؤلفون الرئيسيون:	Li, Shan, Wang, Yuji, Wang, Feng, Wang, Yaonan, Zhang, Xiaoyi, Zhao, Ming, Feng, Qiqi, Wu, Jianhui, Zhao, Shurui, Wu, Wei, Peng, Shiqi
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	Dove Medical Press 2015
الموضوعات:	Original Research
الوصول للمادة أونلاين:	https://ncbi.nlm.nih.gov/pmc/articles/PMC4554418/ https://ncbi.nlm.nih.gov/pubmed/26345234 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S88052
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

Small molecule PZL318: forming fluorescent nanoparticles capable of tracing their interactions with cancer cells and activated platelets, slowing tumor growth and inhibiting thrombosis

مواد مشابهة